Sterling Pharma Solutions has concluded the acquisition of UK-based contract services provider NewChem Technologies for an undisclosed sum.

NewChem has expertise in organic chemistry and serves customers in sectors including pharmaceuticals, biotechnology, diagnostics, veterinary science and chemicals.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Established in 2002 as a spin-off from Newcastle University School of Chemistry, NewChem enhances Sterling’s capabilities in addressing complex process chemistry challenges, synthesising molecules and assisting customers in determining their most viable path for development and scaling up.

Sterling has acquired all the assets and employees of NewChem.

The laboratory facilities of NewChem are situated within Newcastle upon Tyne’s Biosphere.

The site will collaborate closely with Sterling’s facility in Cary, North Carolina, US. This serves as an early-phase development centre.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

NewChem founders Dr Bob Tyson and Professor Bernard Golding will retain their positions as site head and science director.

Sterling CEO Kevin Cook stated: “The expertise and experience within the well-respected and talented NewChem team will provide the business with additional capacity to solve complex chemistry challenges.

“NewChem’s connections with academia are closely aligned with Sterling’s technology and innovation programme, which sees us work with a number of leading global academic institutions to bring the latest technologies and innovations to our customers.”

Sterling’s global presence encompasses its UK headquarters in Cramlington near Newcastle, its manufacturing facility, a newly GMP-licensed bioconjugation centre in Deeside, a 111-acre site in Ringaskiddy, Ireland, and two US locations, in Cary and in Germantown, Wisconsin.

This content was updated on 25 January 2024

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Imagene’s Oncology Intelligence (OI) Suite has won the Innovation Award for Precision Oncology, for transforming how pharma designs and runs oncology trials. From AI-driven biomarker discovery to smarter patient stratification, see how Imagene is cutting time, cost and risk in cancer drug development.

Discover the Impact